From Mandate to Market Leader
Ethicon (Johnson & Johnson): Using CVA to Win in Endoscopy
The Challenge:
When J&J’s CEO laid down the gauntlet — “Become the #1 player in endoscopic surgery within four years” — the Ethicon team knew it faced a mountain.
US Surgical dominated the space, and their team was preparing to strike back at Ethicon’s core suture business with sharper needle technology. Ethicon had two simultaneous objectives: catch and overtake the endoscopy leader — and defend its legacy suture business.
Internally, morale was mixed. The team believed they were far behind in endoscopy and assumed they held an insurmountable lead in sutures. But that was just belief — not fact.
The CVA Breakthrough:
To start, Ethicon conducted CVA team workshops with cross-functional leaders — engineering, marketing, sales, and finance — to build a shared understanding of value. They co-created a Value Scorecard identifying 12 key benefit attributes for each market, including:
- For endoscopy: image clarity, ergonomics, incision size, instrument control, reliability, training/support, and price.
- For sutures: needle sharpness, ease of handling, break strength, infection risk, and support service.
Each team member scored Ethicon and competitors on a 1–10 scale for each attribute and estimated the relative importance from the buyer’s perspective. Those scores were then replaced with actual market survey data from surgeons, capturing how surgeons (not internal teams) perceived each competitor’s performance.
What did the Value Landscape reveal?
To everyone’s surprise, Ethicon wasn’t nearly as far behind in endoscopy as assumed — surgeons rated them higher than expected on ergonomics, reliability, and incision size, and price differences were small. Meanwhile, in sutures, the Value Map showed US Surgical’s needle improvements were closing the gap faster than Ethicon realized.
This shift from “we’re far behind / way ahead” to “we’re close in both” created a decisive mindset change.
Strategic Moves (Powered by CVA):
- Clarified the Path to Leadership
Using the Value Scorecard, the team classified attributes into:
- Catch-up: improve image clarity, where US Surgical still led.
- Pull-ahead: build advantage in ergonomics and reliability.
- Leapfrog: introduce innovations in training and procedure design, not just tools.
- Reorganized for Speed
Created a dedicated Endosurgery business unit in Cincinnati, with a clear mandate: beat US Surgical where it matters. They deployed a CVA War Room, with live performance-for-price maps showing progress vs. competitors and internal initiatives. - Rethought the Offering
Surgeons cared more about procedure quality and training than individual product features. So Ethicon shifted from marketing tools to marketing complete procedures. They pioneered a new minimally invasive hernia repair protocol — and trained surgeons on it at a newly launched training institute, staffed with expert reps who could speak the surgeon’s language. - Used CVA to Track the Market Shift
CVA wasn’t a one-time study. As the market matured, buying influence shifted from surgeons to hospital purchasing teams. Ethicon adjusted its CVA survey panel and scorecard to reflect this — and prioritized attributes like cost-efficiency, standardization, and rep support to win institutional decisions. - Defended the Suture Core with Data
Ethicon’s wound closure team fast-tracked sharper needles after CVA revealed that surgeons slightly overrated US Surgical’s performance. Ethicon used side-by-side performance data in marketing to correct misperceptions and hold share.
The Result:
Within four years, Ethicon Endosurgery overtook US Surgical and became the market leader — hitting the CEO’s goal exactly on time. Meanwhile, the suture team retained its dominant position, protecting J&J’s core.
CVA didn’t just guide strategy — it focused it.
It exposed flawed assumptions, revealed hidden strengths, and prioritized where to act. The tools helped teams answer, “Where do we win, how far are we behind, and what’s it worth to fix it?”
Why It Worked:
“Without CVA, we would have misread both markets. We would’ve chased the wrong things and underinvested where it mattered. Instead, we acted with clarity — and confidence.”
— [Hypothetical quote attributed to a former Ethicon GM for illustration]
This case remains one of the clearest examples of cross-functional CVA in action: customer insight turned into focused operational and commercial action, tracked in real-time.